Next Article in Journal
Nigericin Boosts Anti-Tumor Immune Response via Inducing Pyroptosis in Triple-Negative Breast Cancer
Previous Article in Journal
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells
Previous Article in Special Issue
Integrating Cancer Vaccines in the Standard-of-Care of Ovarian Cancer: Translating Preclinical Models to Human
 
 
Review

Article Versions Notes

Cancers 2023, 15(12), 3220; https://doi.org/10.3390/cancers15123220
Action Date Notes Link
article pdf uploaded. 16 June 2023 15:05 CEST Version of Record https://www.mdpi.com/2072-6694/15/12/3220/pdf-vor
article xml file uploaded 19 June 2023 05:44 CEST Original file -
article xml uploaded. 19 June 2023 05:44 CEST Update https://www.mdpi.com/2072-6694/15/12/3220/xml
article pdf uploaded. 19 June 2023 05:44 CEST Updated version of record https://www.mdpi.com/2072-6694/15/12/3220/pdf
article html file updated 19 June 2023 05:45 CEST Original file -
article html file updated 6 July 2023 20:22 CEST Update https://www.mdpi.com/2072-6694/15/12/3220/html
Back to TopTop